Incyte Genomics, Inc. Community Page | What other sites are saying about Incyte Genomics, Inc.

Incyte Genomics, Inc.

(NQ: INCY)

21.41 USD +0.35 (+1.66%)

Official Closing Price / Updated: 4:00 PM EDT, Jun 18, 2013 / Add to My Watchlist

(INCY) Community Analysis from

Related Wikinvest articles

June 18, 2013

Will Incyte's Blood Cancer Drug Bring Dividends?

(Benzinga, 11/18/11)

Today, Incyte (NASDAQ: INCY) announced that the FDA had approved their blood cancer drug Jakafi that's designed to treat myelofibrosis. The drug is the first to be approved to treat...(read more)

(INCY) Incyte Corporation Analyst Maintains Neutral on Shares

(Stock Blog Hub, 6/16/11)

We are maintaining our Neutral recommendation on Incyte Corporation (INCY) with a target price of $18.00. Incyte is a Wilmington, Delaware-based drug discovery and...(read more)

INCY, MCP, PCS, ZSL Among Charts to Watch

(Wall Street Sector Selector, 5/4/11)

Yesterday we showed you the Boxer Shorts and what they were doing. Certainly there are a lot of negative looking charts, but there are still a lot of bullish ones. Despite the fact that the market had some difficult sessions the last few days, w...

View all posts about Incyte (INCY)

Incyte (INCY) Company Overview

There is no analysis for INCY yet. But you can go to Wikinvest to help create one!

What's in this INCY analysis on Wikinvest...

Read more analysis on Wikinvest

Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates